Cargando…
Deselecting Melanoma Patients for Sentinel Lymph Node Biopsy During COVID-19: Clinical Utility of Tumor Molecular Profiling
Autores principales: | Meves, Alexander, Eggermont, Alexander M.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367022/ https://www.ncbi.nlm.nih.gov/pubmed/32838203 http://dx.doi.org/10.1016/j.mayocpiqo.2020.05.009 |
Ejemplares similares
-
Cutaneous Melanoma and Sentinel Lymph Node Biopsy
por: van Akkooi, A. C. J., et al.
Publicado: (2008) -
Diagnostic biopsy of cutaneous melanoma, sentinel lymph node biopsy and indications for lymphadenectomy
por: Pavlidis, Efstathios T, et al.
Publicado: (2022) -
Cost evaluation of the Merlin assay for predicting melanoma sentinel lymph node biopsy metastasis
por: Thao, Viengneesee, et al.
Publicado: (2022) -
Sentinel Lymph Node Biopsy and Complete Lymph Node Dissection for Melanoma
por: Falk Delgado, Alberto, et al.
Publicado: (2019) -
Breslow thickness 2.0: Why gene expression profiling is a step toward better patient selection for sentinel lymph node biopsies
por: Sadurní, Mariana B., et al.
Publicado: (2022)